“…New approaches and strategies to improve the immunomodulatory and regenerative capacities of MSCs in treating AS should be further investigated. One such strategy is preconditioning under ex vivo conditions in a defined environment using various biological, chemical, or physical factors [ 13 , 26 , 27 , 28 ]. To improve the therapeutic efficacy of MSCs, variable preconditioning approaches have been suggested, including but not limited to cytokines, hypoxia, a 3D culture, the genetic modification of MSCs, and autophagy modeling [ 13 , 26 , 27 ].…”